DKD data was very useful for FSGS trial design.
Failure of DKD could also be down to DXB legacy effect given the cross over trial design.
Advanz are confident, so should we be
Dimerix (ASX: DXB) Discussion Thread, page-482
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
-0.005(1.01%) |
Mkt cap ! $269.3M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 50.5¢ | 48.0¢ | $2.468M | 5.015M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 265677 | 48.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 21469 | 1 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
49.0¢ |
Change
-0.005 ( 1.57 %) |
||||
| Open | High | Low | Volume | ||
| 49.0¢ | 51.0¢ | 48.0¢ | 3218000 | ||
| Last updated 16.01pm 05/06/2024 ? | |||||
| DXB (ASX) Chart |